Novo Nordisk’s research center in Seattle, WA is the epicenter of the company’s R&D activities in the U.S. Teams are part of a global organization, partnering with colleagues across various international research centers. The team in Seattle is focused on early discovery projects within the diabetes and obesity areas. Scientists apply cutting edge technologies to bring molecules to market. Right now, that means identifying protein and stem-cell based therapies for obesity, diabetes and other chronic diseases, as well as research on the next generation of medical devices.

We strive to make a difference in Seattle through support for local organizations and partnerships with the Seattle biotech and academic communities and efforts focused on environmental awareness and health. We place emphasis on alternative means of transportation such as bicycling. Our company has received multiple recognitions and awards from organizations such as the Puget Sound Business Journal and the League of American Bicyclists for being a ‘bicycle-friendly’ business. We also have recycling and composting programs, aligning with the city of Seattle’s initiatives for a cleaner environment.